Najat Khan plans Rule 144 sale of Recursion (NASDAQ: RXRX) shares on 05/15/2026
Rhea-AI Filing Summary
Najat Khan filed a Rule 144 notice to sell Common Stock of Recursion Pharmaceuticals. The filing lists intended sales dated 05/15/2026 of 18,422 shares and 7,788 shares described as Equity Compensation. The excerpt also reports a prior sale of 28,298 shares on 03/09/2026 for $94,662.47.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice documents planned resale of restricted or control stock.
The filing lists specific share amounts and sale dates: 18,422 and 7,788 shares dated 05/15/2026, labeled as Equity Compensation. These entries indicate scheduled dispositions under resale rules rather than new issuances.
Cash‑flow treatment is not stated beyond the prior sale showing $94,662.47 for 28,298 shares on 03/09/2026. Subsequent filings or broker confirmations will show whether these planned sales occurred.